Form 8-K - Current report:
SEC Accession No. 0001104659-24-009817
Filing Date
2024-02-02
Accepted
2024-02-02 10:27:25
Documents
17
Period of Report
2024-01-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244971d1_8k.htm   iXBRL 8-K 29186
2 EXHIBIT 16.1 tm244971d1_ex16-1.htm EX-16.1 2994
6 GRAPHIC tm244971d1_ex16-1img001.jpg GRAPHIC 5378
7 GRAPHIC tm244971d1_ex16-1img002.jpg GRAPHIC 3005
  Complete submission text file 0001104659-24-009817.txt   216834

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acur-20240130.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20240130_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20240130_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT tm244971d1_8k_htm.xml XML 3510
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 24589212
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)